Disability prevalence among men and women are investigated using NLTCS surveys conducted in 1982, 1984, 1989, 1994 and 1999 in the US population, on persons older than 65 years, and data from LSADT surveys conducted in 1995, 1997, 1999 and 2001 in the population of the Danish Twins Registry, on persons older than 75 years. In both surveys women are more disabled than men. The probability of becoming disabled and surviving is higher for women than men. The probability of recovering from a disability differs between the sexes statistically insignificant. No time trends are observed in the probabilities of becoming disabled, reversing disability or dying disabled. Calculations show that a decrease in disability prevalence observed in the USA resulted from a decrease in disability prevalence in ages younger than 65 years. Using LSADT data heritability of disability in women older than 75 years is estimated to be 36% (14%; 54%). In men of the same ages the estimate is 11% (0%; 40%) and for both sexes heritability is estimated at 28% (10%; 45%).

Download full-text PDF

Source

Publication Analysis

Top Keywords

disability prevalence
16
older years
12
prevalence men
8
men women
8
surveys conducted
8
persons older
8
men probability
8
decrease disability
8
disability
6
men
5

Similar Publications

Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program.

PLoS One

January 2025

Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Onychomycosis is a common, difficult to treat nail disorder. Our objective was to explore disparities in current clinical management practices for onychomycosis in patients from underrepresented groups and with specific comorbidities. We conducted a cross-sectional study using the All of Us (AoU) research program.

View Article and Find Full Text PDF

Unlabelled: High rates of childhood neurodisability are reported among the Roma, Europe's largest ethnic minority community. Interventions targeting early child development (ECD) during the first 2 years of life can improve neurodevelopmental outcomes in vulnerable children; however, evidence from Roma preschoolers is scarce. In a quasi-experimental observational study, we compared neurodevelopmental outcomes at age 2 years, measured on the INTERGROWTH-21st Project Neurodevelopmental Assessment (INTER-NDA), between Roma children receiving a community-based ECD intervention (RI, n = 98), and age- and sex-matched Roma and non-Roma children (RC, n = 99 and NRC, n = 54, respectively) who did not receive the intervention in Eastern Slovakia.

View Article and Find Full Text PDF

Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension History.

Stroke

January 2025

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China. (X.X., X.L., Y.P., Yufei Wei, Y.J., M.W., J.J., X.M., Yilong Wang, Yongjun Wang, L.L.).

Background: We performed a prespecified subgroup analysis of the CATIS-2 trial (China Antihypertensive Trial in Acute Ischemic Stroke II) to compare the effect of early versus delayed antihypertensive treatment on death and disability in patients with and without medical history of hypertension.

Methods: CATIS-2 is a multicenter randomized clinical trial conducted in 106 hospitals in China. The trial randomized 4810 patients with acute ischemic stroke within 24 to 48 hours of symptom onset and elevated systolic blood pressure between 140 and <220 mm Hg to receive antihypertensive treatment immediately after randomization or to discontinue antihypertensive medications for 7 days and then receive treatment on day 8.

View Article and Find Full Text PDF

Introduction: Living with a chronic disease impacts many aspects of life, including the ability to participate in activities that enable interactions with others in society, that is, social participation (SP). Despite efforts to monitor the quality of care and life of chronically ill people in Belgium, no disease-specific patient-reported measures (PRMs) have been used. These tools are essential to understand SP and to develop evidence-based recommendations to support its improvement.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is a significant contributor to the global burden of disease. Among its causes, chronic kidney disease due to type 2 diabetes (CKD-T2D) is the primary subtype. This study aims to provide an updated assessment of the global disease burden of CKD-T2D from 1990 to 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!